Enhancing blood test accuracy using new technology
Official title: Improving ELISA Technology using Ultra-efficient Peroxidase Mimics
Funded at University of Central Florida · NIH-11055328 · Data updated 2026-11-12
This study is exploring a new way to make blood tests for conditions like cancer more accurate and sensitive by using tiny particles that act like enzymes, which could help doctors catch diseases earlier.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Central Florida NIH-funded |
| Lab location | 1 site (Orlando, United States) |
| Project start | March 13, 2024 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $290,185 |
| NIH project number | 5R01EB035519-02 |
| Project ID | NIH-11055328 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who require blood tests for the detection of biomarkers related to cancer or other serious conditions.
✕Less likely to help
Patients who do not require blood tests or those with conditions that are not detectable through biomarkers may not benefit from this research.
What this research studies
This research focuses on improving the enzyme-linked immunosorbent assay (ELISA) technology, which is commonly used for diagnosing various conditions, including cancer. The study aims to develop a new method using nanoparticles that can mimic the action of enzymes, significantly increasing the sensitivity and accuracy of blood tests. By utilizing these nanoparticles, the researchers hope to achieve better detection limits for biomarkers, which could lead to earlier diagnosis of diseases. This innovative approach could transform how blood tests are conducted in clinical settings.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and earlier detection of diseases, particularly cancers, improving patient outcomes.
How similar studies have gone: Other research has shown promise in using nanoparticles for enhancing diagnostic tests, indicating that this approach could be a significant advancement in the field.
Where this research is happening
-
University of Central Florida
Orlando, United States Active
Researchers
- Principal investigator: Xia, Xiaohu — University of Central Florida
- Study coordinator: Xia, Xiaohu
Related research
Other NIH-funded projects on the same topics.
-
Sexually Transmitted Infection Testing Risk and Prevention among Trans Women
A study to improve STI testing and prevention for trans women by testing self-collection vs clinician collection, and by measuring STI prevalence across sites and how social factors influence risk.
-
Collaborative AI for safer, faster bacteremia care
A physician-centered AI system is being built to help diagnose and treat bloodstream infections more accurately and safely, with the goal of reducing sepsis deaths.
-
Bayesian data tools to map and fight syphilis and congenital syphilis
A data-driven, bayesian approach will turn messy health data into clear, local-level insights to prevent congenital syphilis and reduce syphilis in communities.
-
Harnessing neuron-derived vesicles to find Huntington’s disease biomarkers
A research project aims to identify brain-derived biomarkers in blood that reflect Huntington disease activity, using neuronal extracellular vesicles as the signal source.
-
Heart nerves: mapping how the heart’s sensing nerves connect in health and diabetes
This project maps the nerve pathways that sense heart signals in healthy and diabetic hearts to identify targets for therapies that could reduce heart injury.
-
Strengths-based suicide prevention for Black sexual minority youth
A research project aims to help Black sexual minority youth reduce suicidal thoughts and behaviors by understanding protective factors and risks in everyday life.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.